CMBT vs PTEN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CMBT presents a contradictory profile: explosive revenue growth (160% YoY) paired with a deteriorating earnings track record and poor liquidity. While the Piotroski F-Score of 6/9 indicates stable financial health, the company has missed earnings estimates in 4 consecutive quarters with a severe average surprise of -156.54%. The stock trades slightly above its Graham Number ($11.93) and significantly above its growth-based intrinsic value ($4.90), suggesting a valuation premium that is not currently supported by bottom-line performance. High leverage (Debt/Equity 2.12) and a current ratio below 1.0 create a precarious financial position despite strong operating margins.
PTEN exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating deteriorating financial health. Despite a strong one-year price rally, the company is currently unprofitable with negative margins and a dividend payout ratio of 213.33%, which is fundamentally unsustainable. Bearish insider activity and a sharp decline in technical trend (10/100) suggest that the recent price surge may have been a speculative peak rather than a reflection of intrinsic value.
Compare Another Pair
Related Comparisons
CMBT vs PTEN: Head-to-Head Comparison
This page compares Cmb.Tech NV (CMBT) and Patterson-UTI Energy, Inc. (PTEN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.